ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy

Yuan, Xinyuan; Wang, Xiupeng*6; 1
Nanomaterials2023-12DOI: 10.3390/nano13243144
11阅读
引用收藏
分享

摘要

Clinically, cancer chemotherapy still faces unsatisfactory efficacy due to drug resistance and severe side effects, including tiredness, hair loss, feeling sick, etc. The clinical benefits of checkpoint inhibitors have revived hope for cancer immunotherapy, but the objective response rate of immune checkpoint inhibitors remains around 10-40%. Herein, two types of copper-doped mesoporous silica nanoparticles (MS-Cu-1 with a diameter of about 30 nm and MS-Cu-2 with a diameter of about 200 nm) were synthesized using a one-pot method. Both MS-Cu-1 and MS-Cu-2 nanoparticles showed excellent tumor microenvironment regulation properties with elevated extracellular and intracellular ROS generation, extracellular and intracellular oxygenation, and intracellular GSH depletion. In particular, MS-Cu-2 nanoparticles demonstrated a better microenvironment modulation effect than MS-Cu-1 nanoparticles. The DSF/MS-Cu composites with disulfiram (DSF) and copper co-delivery characteristics were prepared by a straightforward method using chloroform as the solvent. Cell survival rate and live/dead staining results showed that DSF and MS-Cu alone were not toxic to LLC cells, while a low dose of DSF/MS-Cu (1-10 mu g/mL) showed a strong cell-killing effect. In addition, MS-Cu-2 nanoparticles released more Cu2+ in a weakly acidic environment (pH = 5) than in a physiological environment (pH = 7.4), and the Cu2+ released was 41.72 +/- 0.96 mg/L in 1 h under weakly acidic conditions. UV-visible absorption spectrometry confirmed the production of tumor-killing drugs (CuETs). The intratumoral injection of DSF/MS-Cu significantly inhibited tumor growth in vivo by converting nontoxic DSF/MS-Cu into toxic CuETs. The combination of DSF/MS-Cu and anti-CTLA-4 antibody further inhibited tumor growth, showing the synergistic effect of DSF/MS-Cu and immune checkpoint inhibitors.

学科与关键词

关键词
copper-dopped mesoporous silica (MS-Cu)disulfiram (DSF)chemoimmunotherapytumor environment regulationnontoxic to toxic
相关
加载中…
  • Cu2+-Chelating Mesoporous Silica Nanoparticles for Synergistic Chemotherapy/Chemodynamic Therapy
    Zhang, Yanyan; Lou, Jiadong; Williams, Gareth R.; Ye, Yuhan; Ren, Dandan; Shi, Anhua; Wu, Junzi; Chen, Wenling*; Zhu, Li-Min*Pharmaceutics, 2022, 14(6): 1200.被引 2
  • Coordination and Redox Dual-Responsive Mesoporous Organosilica Nanoparticles Amplify Immunogenic Cell Death for Cancer Chemoimmunotherapy
    Zhang, Fan; Chen, Fangman; Yang, Chao; Wang, Lei; Hu, Hanze; Li, Xuezhao; Zheng, Xiao; Wang, Zheng; Chang, Zhimin; Li, Tianyu; Li, Li; Ge, Mingfeng; Du, Jinzhi; Sun, Wen*; Dong, Wen-Fei*; Shao, Dan*Small, 2021, 17(26): 2100006.被引 49
  • Leveraging efferocytosis blockade for improved cancer chemo-immunotherapy through synchronized release of doxorubicin and BMS777607 confined within tailored mesoporous silica nanoparticles
    Zhang, Jing-Yang; Chen, Fang-Man; Li, Yu-Xuan; Duan, Qi-Jia; Wu, Chong; Zheng, Sui-Juan; Leong, Kam W.; Shao, Dan*; Du, Jin-Zhi*Nano Today, 2023, 53: 102039.
查看全部 →

发表信息

论文状态
公开发表
期刊
Nanomaterials
发表日期
2023-12
卷期
第 13 卷, 第 24 期
页码
3144
DOI
10.3390/nano13243144
语言
ENGLISH
成果收录
SCIE
资助标注
JSPS KAKENHI

作者

  • Y

    Yuan, Xinyuan (第一作者)

  • W

    Wang, Xiupeng (通讯)

    1 · 6

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417